Clinical Trial Update: A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating injectable secretin (Chirostim) on pancreatic fluid composition in healthy subjects is sponsored by Mayo Clinic and not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• Chirostim (secretin)

Snippet

Sponsor: Mayo Clinic | Conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Phase 4 | Status: NOT_YET_RECRUITING